Posterior reversible encephalopathy syndrome: A rare complication of rituximab therapy in rheumatoid arthritis

Rituximab, a murine-human chimeric monoclonal antibody targeting CD20-positive B lymphocytes, has established itself as an effective and relatively safe biologic therapy for patients with refractory rheumatoid arthritis. Most common side effects associated with its use include infusion related react...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain Awan, Marriam, Samreen, Saba, Perveen, Shahida, Salim, Babur, Gul, Haris, Khan, Anum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362588/
https://www.ncbi.nlm.nih.gov/pubmed/37485477
http://dx.doi.org/10.2478/rir-2023-0014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362588/
https://www.ncbi.nlm.nih.gov/pubmed/37485477
http://dx.doi.org/10.2478/rir-2023-0014

Ejemplares similares